The role of radical prostatectomy as an initial approach for the treatment of high-risk prostate cancer

被引:2
作者
Jaunarena, J. H. [1 ]
Villamil, W. [1 ]
Martinez, P. F. [1 ]
Gueglio, G. [1 ]
Giudice, C. R. [1 ]
机构
[1] Hosp Italiano Buenos Aires, Serv Urol, Buenos Aires, DF, Argentina
来源
ACTAS UROLOGICAS ESPANOLAS | 2016年 / 40卷 / 06期
关键词
Prostate cancer; High-risk; Radical prostatectomy; Biochemical recurrence; Radiation therapy; Cancer-specific mortality; EXTERNAL-BEAM RADIOTHERAPY; METASTATIC PROGRESSION; RANDOMIZED-TRIAL; MORTALITY; THERAPY; DEFINITION; MANAGEMENT; OUTCOMES; IMPACT; MEN;
D O I
10.1016/j.acuro.2015.12.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Context: The treatment of high-risk prostate cancer requires a multimodal approach to improve control of the disease. There is still no consensus as to the initial strategy of choice. The aim of this study is to review the results of radical prostatectomy as first step in management of patients with high-risk disease. Acquisition of evidence: A search was conducted on PubMed of English and Spanish texts. We included those studies that reported the results of radical prostatectomy in patients with high risk prostate cancer, as well as those that compared radical prostatectomy with other treatment alternatives. The last search was conducted in November 2015. Synthesis of the evidence: The advantages of radical prostatectomy include a better pathological analysis, more accurate staging, better local control of the disease and better follow-up and adjuvant therapy strategies. When compared with external radiation therapy plus hormonal blockade, the patients who underwent prostatectomy had greater chances of healing and longer cancer-specific survival. The patients who most benefit from this approach are younger, have fewer comorbidities and no evidence of organ metastases. Conclusions: The available scientific evidence to date is not without bias and confounders; however, they appear to favour radical prostatectomy as the initial approach of choice for high-risk prostate cancer. (C) 2015 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 40 条
  • [1] More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer
    Abdollah, Firas
    Gandaglia, Giorgio
    Suardi, Nazareno
    Capitanio, Umberto
    Salonia, Andrea
    Nini, Alessandro
    Moschini, Marco
    Sun, Maxine
    Karakiewicz, Pierre I.
    Shariat, Sharhokh F.
    Montorsi, Francesco
    Briganti, Alberto
    [J]. EUROPEAN UROLOGY, 2015, 67 (02) : 212 - 219
  • [2] Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis
    Abdollah, Firas
    Schmitges, Jan
    Sun, Maxine
    Jeldres, Claudio
    Tian, Zhe
    Briganti, Alberto
    Shariat, Shahrokh F.
    Perrotte, Paul
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (09) : 836 - 844
  • [3] The Impact of Pathologic Staging on the Long-Term Oncologic Outcomes of Patients With Clinically High-Risk Prostate Cancer
    Abern, Michael R.
    Terris, Martha K.
    Aronson, William J.
    Kane, Christopher J.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Freedland, Stephen J.
    [J]. CANCER, 2014, 120 (11) : 1656 - 1662
  • [4] A Randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: Results at median follow-up of 102 months
    Akakura, Koichiro
    Suzuki, Hiroyoshi
    Ichikawa, Tomohiko
    Fujimoto, Hiroyuki
    Maeda, Osamu
    Usami, Michiyuki
    Hirano, Daisaku
    Takimoto, Yukie
    Kamoto, Toshiyuki
    Ogawa, Osamu
    Sumiyoshi, Yoshiteru
    Shimazaki, Jun
    Kakizoe, Tadao
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (12) : 789 - 793
  • [5] [Anonymous], EUR UROL
  • [6] The status of surgery in the management of high-risk prostate cancer
    Bach, Christian
    Pisipati, Sailaja
    Daneshwar, Datesh
    Wright, Mark
    Rowe, Edward
    Gillett, David
    Persad, Raj
    Koupparis, Anthony
    [J]. NATURE REVIEWS UROLOGY, 2014, 11 (06) : 342 - 351
  • [7] Boorjian S, 2012, CANCER, V117, P2883
  • [8] High-risk prostate cancer-classification and therapy
    Chang, Albert J.
    Autio, Karen A.
    Roach, Mack, III
    Scher, Howard I.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (06) : 308 - 323
  • [9] The role of radical prostatectomy in high-risk prostate cancer
    Chung, Byung Ha
    [J]. PROSTATE INTERNATIONAL, 2013, 1 (03) : 95 - 101
  • [10] Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Blank, K
    Broderick, GA
    Tomaszewski, JE
    Renshaw, AA
    Kaplan, I
    Beard, CJ
    Wein, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11): : 969 - 974